Inhibitor Economics
- 30 April 2006
- journal article
- review article
- Published by Elsevier BV in Seminars in Hematology
- Vol. 43, S14-S17
- https://doi.org/10.1053/j.seminhematol.2006.03.004
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Treatment patterns and cost-of-illness of severe haemophilia in patients with inhibitors in GermanyHaemophilia, 2004
- The economic impact of factor VIII inhibitors in patients with haemophiliaHaemophilia, 2004
- Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study GroupBlood, 2003
- Economic modelling of different treatment strategies for haemophilia A with high‐responding inhibitorsHaemophilia, 2003
- Cost related to replacement therapy during hospitalization in haemophiliacs with or without inhibitors: experience of six French haemophilia centresHaemophilia, 2002
- The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO)British Journal of Haematology, 2000
- Immune tolerance induction in hemophilia patients with inhibitors: costly can be cheaperBlood, 2000
- Treatment of patients with inhibitors: cost issuesHaemophilia, 1999
- The impact of inhibitors on the cost of clotting factor replacement therapy in haemophilia A in CanadaHaemophilia, 1999
- Hemophilia Home Treatment:Economic Analysis and Implications for Health PolicyInternational Journal of Technology Assessment in Health Care, 1995